11 reports

MARKET ##.

  • Diabetes
  • Diagnostics
  • DNA
  • Canada
  • Company Financials
  • Deal in Brief
  • Deal in Brief

Each unit is consists of one common share and one-half of one share purchase warrant.

  • Diabetes
  • Medical Device
  • Medical Equipment
  • Canada
  • Company

Each unit consists of one common share and one half of one common share purchase warrant.

  • Diabetes
  • Healthcare
  • Pharmaceutical
  • Canada
  • Miraculins Inc.

Each unit consists of one common share and one half of one common share purchase warrant.

  • Diabetes
  • Healthcare
  • Pharmaceutical
  • Canada
  • Miraculins Inc.

HAS ACQUIRED A ##% STAKE IN PATHOGEN REMOVAL AND DIAGNOSTIC TECHNOLOGIES, INC.

  • Diabetes
  • Immunology
  • Pharmaceutical
  • Canada
  • ProMetic Life Sciences Inc.

PARTNER ##: CEAPRO INC.

  • Cardiology
  • Diabetes
  • Canada
  • Company
  • Ceapro Inc.
  • MIRACULINS INC. COMPANY OVERVIEW
  • JAN 27, 2015: MIRACULINS ANNOUNCES RETAIL PHARMACY PILOT FOR ITS SCOUT DS DIABETES SCREEN

Clinical Trials by Trial Status Trial Status No of Clinical Trials Colorectal Cancer ## Coronary Artery Disease ## Diabetes Mellitus ## Gastric Cancer ## Pancreatic Cancer ## Preeclampsia ## Prostate Cancer ## Ongoing, not Recruiting

  • Colorectal Cancer
  • Diabetes
  • Pharmacy
  • Canada
  • Miraculins Inc.

PARTNER ##: ANGES MG, INC.

  • Diabetes
  • Canada
  • Company
  • Corporate Finance
  • Mitsubishi Corporation

HAS ACQUIRED A ##% STAKE IN PATHOGEN REMOVAL AND DIAGNOSTIC TECHNOLOGIES, INC.

  • Diabetes
  • Immunology
  • Pharmaceutical
  • Canada
  • ProMetic Life Sciences Inc.

Company type Business description COMPANY INFORMATION: PARTNERS PARTNER ##: INNOVATIVE TARGETING SOLUTIONS, INC.

  • Diabetes
  • Immunology
  • Pharmaceutical
  • Canada
  • Zymeworks Inc.

PARTNER ##: ANGES MG, INC.

  • Diabetes
  • Canada
  • Company
  • Corporate Finance
  • Mitsubishi Corporation